Funding for this research was provided by:
National Natural Science Foundation of China (31700798)
Health science and technology project of yunnan province (NO. 2017NS214, 2017NS215,2017NS216,2018NS0235,2018NS0236)
Martin expert workstation (2018IC106)
Yunnan Province Famous Doctor Plan (YNWR-MY-2018-014)
Yunnan Clinical Medical Center for Reproductive Genetic Diseases (ZX2019-01-01)
Received: 12 April 2020
Accepted: 9 October 2020
First Online: 22 October 2020
Ethics approval and consent to participate
: This study was conducted in accordance with the declaration of Helsinki.This study was conducted with approval from the Ethics Committee of The First People’s Hospital of Yunnan Provience.A written informed consent was obtained from all participants.
: Consent for publication was obtained from every individual whose data are included in this manuscript.
: All authors have contributed significantly to the manuscript and declare that the work is original and has not been submitted or published elsewhere. None of the authors have any financial disclosure or conflict of interest.